Clinical Trial Update: Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical-trial update reports Phase 1/2 results for disulfiram aimed at reducing fatigue and improving quality of life in patients with previously treated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Drugs mentioned

• Disulfiram (Disulfiram)

Snippet

Sponsor: Research Foundation for Mental Hygiene, Inc. | Conditions: Fatigue, Quality of Life | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-06-05